Close

Aquestive Therapeutics (AQST) PT Lowered to $5 at H.C. Wainwright

September 6, 2022 6:39 AM EDT Send to a Friend
H.C. Wainwright analyst Raghuram Selvaraju lowered the price target on Aquestive Therapeutics (NASDAQ: AQST) to $5.00 (from $6.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login